Compare · SMTI vs ZBH
SMTI vs ZBH
Side-by-side comparison of Sanara MedTech Inc. (SMTI) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SMTI and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $17.67B, about 100.3x SMTI ($176.1M).
- Over the past year, SMTI is down 38.9% and ZBH is down 10.2% - ZBH leads by 28.6 points.
- SMTI has been more active in the news (6 items in the past 4 weeks vs 2 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 5 for SMTI).
- Company
- Sanara MedTech Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $19.20-0.39%
- $91.33-1.18%
- Market cap
- $176.1M
- $17.67B
- 1M return
- +17.57%
- +4.25%
- 1Y return
- -38.88%
- -10.23%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 6
- 2
- Recent ratings
- 5
- 25
Sanara MedTech Inc.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. It also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers; and PULSAR II Advanced Wound Irrigation System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest SMTI
- SEC Form DEFA14A filed by Sanara MedTech Inc.
- SEC Form DEFA14A filed by Sanara MedTech Inc.
- SEC Form DEF 14A filed by Sanara MedTech Inc.
- SEC Form 4 filed by Waldrop Jacob A.
- Lake Street initiated coverage on Sanara MedTech with a new price target
- Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
- SEC Form 10-K filed by Sanara MedTech Inc.
- Sanara MedTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
- SEC Form 4 filed by Mackey Ashley M
Latest ZBH
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- SEC Form 4 filed by Noor Jehanzeb
- SEC Form 4 filed by Jafry Syed A.
- SEC Form 4 filed by Kolli Sreelakshmi
- SEC Form 4 filed by Shapiro Louis
- SEC Form 4 filed by Hilado Maria Teresa
- SEC Form 4 filed by Higgins Arthur J
- SEC Form 4 filed by Kurdikar Devdatt
- SEC Form 4 filed by Hagemann Robert